Free tool
FAERS Monitor: Myrbetriq Granules
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 213801 or its brand name (Myrbetriq Granules, Mirabegron). Reports on generic versions are filed under their own applications.
Reports
39,172
Serious
19,045
49% of reports
Hospitalization
8,034
Death reported
3,335
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective5,971
- off label use2,852
- fatigue2,372
- headache2,301
- dizziness2,293
- fall2,069
- diarrhoea2,057
- pain1,921
- nausea1,831
- asthenia1,638
- hypertension1,593
- intentional product misuse1,549
- arthralgia1,538
- blood pressure increased1,503
- dry mouth1,502
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 64 |
| 2013 | 1,374 |
| 2014 | 1,949 |
| 2015 | 2,022 |
| 2016 | 2,731 |
| 2017 | 3,683 |
| 2018 | 3,916 |
| 2019 | 3,313 |
| 2020 | 3,039 |
| 2021 | 2,867 |
| 2022 | 2,797 |
| 2023 | 2,843 |
| 2024 | 3,150 |
| 2025 | 3,300 |
| 2026 | 2,119 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,014,987 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dry mouthSignal | 1,502 | 10.1 | 9.6 | 12,137 |
| intentional product misuseSignal | 1,549 | 9.7 | 9.2 | 11,843 |
| blood pressure increasedSignal | 1,503 | 5.3 | 5.1 | 5,256 |
| hypertensionSignal | 1,593 | 4.1 | 3.9 | 3,683 |
| fallSignal | 2,069 | 3.4 | 3.2 | 3,447 |
| dizzinessSignal | 2,293 | 2.5 | 2.4 | 2,054 |
| drug ineffectiveSignal | 5,971 | 2.4 | 2.4 | 5,383 |
| astheniaSignal | 1,638 | 2.3 | 2.2 | 1,280 |
| arthralgia | 1,538 | 2.0 | 1.9 | 769 |
| headache | 2,301 | 2.0 | 1.9 | 1,135 |
| off label use | 2,852 | 1.8 | 1.7 | 955 |
| diarrhoea | 2,057 | 1.7 | 1.6 | 627 |
| pain | 1,921 | 1.7 | 1.6 | 544 |
| fatigue | 2,372 | 1.6 | 1.6 | 609 |
| nausea | 1,831 | 1.2 | 1.2 | 90 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.